Pharmacopsychiatry 2015; 48(06): 205-210
DOI: 10.1055/s-0035-1559621
DOI: 10.1055/s-0035-1559621
Original Paper
Treating Depression with Botulinum Toxin: A Pooled Analysis of Randomized Controlled Trials
M. Magid
*
1
Department of Psychiatry, University of Texas at Austin, Dell Medical School, Austin,
TX, USA (MM)
,
E. Finzi
*
2
Department of Psychiatry, George Washington School of Medicine, USA
,
T. H. C. Kruger
*
3
Department of Psychiatry, Social Psychiatry and Psychotherapy, Medical School Hannover,
Germany (THCK, SJ)
,
H. T. Robertson
4
Department of Analytics, Seton Family of Hospitals, Austin, TX, USA (HR)
,
B. H. Keeling
5
Department of Dermatology, University of Texas at Austin, Dell Medical School, Austin,
TX, USA (BHK, JSR)
,
S. Jung
3
Department of Psychiatry, Social Psychiatry and Psychotherapy, Medical School Hannover,
Germany (THCK, SJ)
8
Asklepios Clinic North – Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis
University, Germany (SJ, MAW)
,
J. S. Reichenberg
5
Department of Dermatology, University of Texas at Austin, Dell Medical School, Austin,
TX, USA (BHK, JSR)
,
N. E. Rosenthal
6
Capital Clinical Research Associates, Rockville, MD, USA (NER)
7
Georgetown Medical School, Washington, DC, USA (NER)
,
M. A. Wollmer
8
Asklepios Clinic North – Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis
University, Germany (SJ, MAW)
9
Psychiatric Clinics of the University of Basel, Switzerland (MAW)
› Institutsangaben
